Floatz logo

Therapeutic Asset Ratings

766 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[Lu-177]-Pnt6555
Pancreatic Ductal Adenocarcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1C (37)
Lutetium [177Lu] Bl-Arc001
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Lutetium [177Lu] Bl-Arc001
Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Lutetium [177Lu] Bl-Arc001
Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
rad301
Cervical Cancer
Radiopharm Theranostics, LtdP1C (37)
rad301
Endometrial Carcinoma
Radiopharm Theranostics, LtdP1C (37)
rad301
Pancreatic Ductal Adenocarcinoma
Radiopharm Theranostics, LtdP1C (37)
Yttrium-90
Colorectal Cancer Metastatic
Zhongda HospitalP1C (37)
Zirconium Zr 89-Dfo-Ys5
Metastatic Prostate Carcinoma
Robert Flavell, MD, PhDP1C (37)
Zirconium Zr 89-Dfo-Ys5
Solid Tumor, Adult
Robert Flavell, MD, PhDP1C (37)
212pb-ng001
Metastatic Prostate Carcinoma
ARTBIO Inc.Early P1C (37)
[111in]-fpi-2058
Colorectal Cancer
3B Pharmaceuticals GmbHP1C (36)
[111in]-fpi-2107
Cancer
AstraZenecaP1C (36)
177lu-dfc413
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
177lu-dfc413
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
[177lu]lu-evs459
Ovarian Cancer
Novartis PharmaceuticalsP1C (36)
[177lu]lu-nns309
Colorectal Cancer
Novartis PharmaceuticalsP1C (36)
[177lu]lu-nns309
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (36)
[177lu]lu-xt117
Cancer
Ruimin WangP1C (36)
18f-trx
Neoplasm
Rahul AggarwalP1C (36)
²¹²pb-dotam-grpr1
Breast Cancer
Orano Med Theranostics, SASP1C (36)
225ac-fapi-xt
Cancer
Xiaorong SunP1C (36)
225ac-psma-r2
Prostate Cancer
Novartis PharmaceuticalsP1C (36)
[225]-fpi-2059
Colorectal Cancer
3B Pharmaceuticals GmbHP1C (36)
[68ga]ga-dwj155
Breast Cancer
Novartis PharmaceuticalsP1C (36)
Showing 551 to 575 of 766 assets
PreviousPage 23 of 31Next